Cocaine, Myocardial Infarction, and β-Blockers: Time to Rethink the Equation?

Annals of Emergency Medicine

Volumn 51, Issue 2, 2008, Pages 130-134

  Freeman, Kalev ^a   Feldman, James A ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BENZOYLECGONINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; COCAINE; ESMOLOL; GLYCERYL TRINITRATE; NORADRENALIN; PROPRANOLOL;

ACUTE CORONARY SYNDROME; ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE; CARDIOTOXICITY; CATECHOLAMINE RELEASE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COCAINE DEPENDENCE; CONGESTIVE HEART FAILURE; CORONARY ARTERY SPASM; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INTOXICATION; DRUG OVERDOSE; DRUG SCREENING; DRUG URINE LEVEL; EDITORIAL; ELECTROCARDIOGRAM; EMERGENCY TREATMENT; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART INFARCTION; HEART REINFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSE RATE; SIDE EFFECT; ST SEGMENT ELEVATION; SURVIVAL RATE; TELEMETRY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ADRENERGIC BETA-ANTAGONISTS; COCAINE-RELATED DISORDERS; HEART CATHETERIZATION; HUMANS; MYOCARDIAL INFARCTION;

EID: 38349175326     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2007.08.020     Document Type: Editorial

References (56)

1. Rappolt R.T., Gray G.R., and Inaba D.S. Propranolol in the treatment of cardiopressor effect of cocaine [letter]. N Engl J Med 295 (1976) 448
2. Rappolt R.T., Gay G., Inaba D.S., et al. Propranolol in cocaine toxicity. Lancet 2 (1976) 640-641
3. Rappolt R.T., Gay G.R., and Inaba D.S. Propranolol: a specific antagonist to cocaine. Clin Toxicol 10 (1977) 265-271
4. Coleman D.L., Ross T.F., and Naughton J.L. Myocardial ischemia and infarction related to recreational cocaine use. West J Med 136 (1982) 444-446
5. Ramoska E., and Sacchetti A.D. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med 14 (1985) 1112-1113
6. Hollander J.E. The management of cocaine-associated myocardial ischemia. N Engl J Med 333 (1995) 1267-1272
7. Chen Z.M., Pan H.C., Chen Y.P., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1622-1632
8. American Heart Association. Guidelines for cardiopulmonary resucitation emergency cardiovascular care. Circulation 102 suppl I (2000) I-1-I-384
9. Albertson T.E., Dawson A., de Latorre F., et al., American Heart Association, International Liaison Committee on Resuscitation. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 37 suppl 4 (2001) S78-S90
10. Antman E.M., Anbe D.T., Armstrong P.W., et al., American College of Cardiology, American Heart Association Task Force on Practice Guidelines, Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
11. ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 112 suppl 24 (2005) IV1-IV203
12. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 116 (2007) e148-e304
13. Dattilo P.B., Hailpern S.M., Fearon K., et al. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med 51 (2008) 117-125
14. Mann D.L., Kent R.L., Parsons B., et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85 (1992) 790-804
15. Communal C., Singh K., Pimentel D.R., et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 98 (1998) 1329-1334
16. Lefkowitz R.J., Rockman H.A., and Koch W.J. Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation 101 (2000) 1634-1637
17. Bristow M.R. Beta-adrenergic receptor blockade in chronic heart failure. Circulation 101 (2000) 558-569
18. Cleland J.F.G., Freemantle N., Eastaugh J.L., et al. Beta-blockers for heart failure. Cochrane Database of Systematic Reviews Issue 2 (2000) Art. No.: CD002131. DOI: 10.1002/14651858.CD002131.
19. Ventura H.O. Benefits of inpatient initiation of beta-blockers. American Heart Journal 148 (2004) 944-950
20. Kopecky S.L. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction. American Journal of Cardiology 98 (2006) 1115-1119
21. Minor Jr. R.L., Scott B.D., Brown D.D., et al. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 115 (1991) 797-806
22. Schachne J.S., Roberts B.H., and Thompson P.D. Coronary-artery spasm and myocardial infarction associated with cocaine use. N Engl J Med 310 (1984) 1665-1666
23. Zimmerman F.H., Gustafson G.M., and Kemp Jr. H.G. Recurrent myocardial infarction associated with cocaine abuse in a young man with normal coronary arteries: evidence for coronary artery spasm culminating in thrombosis. J Am Coll Cardiol 9 (1987) 964-968
24. Brogan W.C., Lange R.A., Glamann D.B., et al. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med 116 (1992) 556-561
25. Lange R.A., Cigarroa R.G., Yancy Jr. C.W., et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 321 (1989) 1557-1562
26. Lange R.A., Cigarroa R.G., Flores E.D., et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 112 (1990) 897-903
27. Lange R.A., and Hillis L.D. Cardiovascular complications of cocaine use. N Engl J Med 345 (2001) 351-358
28. Derlet R.W., and Horowitz B.Z. Cardiotoxic drugs. Emerg Med Clin North Am 13 (1995) 771-791
29. Majid P.A., Cheirif J.B., Rokey R., et al. Does cocaine cause coronary vasospasm in chronic cocaine abusers? A study of coronary and systemic hemodynamics. Clin Cardiol 15 (1992) 253-258
30. Feldman J.A., Bui L.D., Mitchell P.M., et al. The evaluation of cocaine-induced chest pain with acute myocardial perfusion imaging. Acad Emerg Med 6 (1999) 103-109
31. Kontos M.C., Schmidt K.L., Nicholson C.S., et al. Myocardial perfusion imaging with technetium-99m sestamibi in patients with cocaine-associated chest pain. Ann Emerg Med 33 (1999) 639-645
32. Benzaquen B.S., Cohen V., and Eisenberg M.J. Effects of cocaine on the coronary arteries. Am Heart J 142 (2001) 402-410
33. Boehrer J.D., Moliterno D.J., Willard J.E., et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 94 (1993) 608-610
34. Sand I.C., Brody S.L., Wrenn K.D., et al. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med 9 (1991) 161-163
35. Vargas R., Gillis R.A., and Ramwell P.W. Propranolol promotes cocaine-induced spasm of porcine coronary artery. J Pharmacol Exp Ther 257 (1991) 644-646
36. Smith M., Garner D., and Niemann J.T. Pharmacologic interventions after an LD50 cocaine insult in a chronically instrumented rat model: are beta-blockers contraindicated?. Ann Emerg Med 20 (1991) 768-771
37. Guinn M.M., Bedford J.A., and Wilson M.C. Antagonism of intravenous cocaine lethality in nonhuman primates. Clin Toxicol 16 (1980) 499-508
38. Selye H. A syndrome produced by diverse nocuous agents. Nature 138 (1936) 32
39. Ahlquist R.P. A study of the adrenotropic receptors. Am J Physiol 153 (1948) 586-600
40. Wiesbauer F., Schlager O., Domanovits H., et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg 104 (2007) 27-41
41. Venkataraman R. Vascular surgery critical care: perioperative cardiac optimization to improve survival. Crit Care Med 34 9 suppl (2006) S200-S207
42. Neil-Dwyer G., Walter P., Cruickshank J.M., et al. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. BMJ 2 (1978) 990-992
43. Hamann G., Haass A., and Schimrigk K. Beta-blockade in acute aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 121 (1993) 119-122
44. Robertson C.S., Clifton G.L., Taylor A.A., et al. Treatment of hypertension associated with head injury. J Neurosurg 59 (1983) 455-460
45. Cotton B.A., Snodgrass K.B., Fleming S.B., et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma 62 (2007) 26-33
46. Arbabi S., Campion E.M., Hemmila M.R., et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma 62 (2007) 56-61
47. James T.L., Feldman J., and Mehta S.D. Physician variability in history taking when evaluating patients presenting with chest pain in the emergency department. Acad Emerg Med 13 (2006) 147-152
48. Gilbert E.H., Lowenstein S.R., Koziol-McLain J., et al. Chart reviews in emergency medicine research: where are the methods?. Ann Emerg Med 27 (1996) 305-308
49. Vandevenne M., Vandenbussche H., and Verstraete A. Detection time of drugs of abuse in urine. Acta Clin Belg 55 (2000) 323-333
50. Shah B.R., Laupacis A., Hux J.E., et al. Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol 58 (2005) 550-559
51. Sturmer T., Joshi M., Glynn R.J., et al. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 59 (2006) 437-447
52. Longstreth Jr. W.T., Fahrenbruch C.E., and Koepsell T.D. Propensity scores for rare outcomes and common treatments. Ann Intern Med 139 (2003) 152-153
53. Waagstein F., Hjalmarson A., Varnauskas E., et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Heart 37 (1975) 1022-1036
54. Chatterjee K. The fear of beta-blocker therapy in heart failure: time to forget. Arch Intern Med 164 (2004) 1370-1371
55. Bates E.R. Role of intravenous beta-blockers in the treatment of ST-elevation myocardial infarction: of mice (dogs, pigs) and men. Circulation 115 (2007) 2904-2906
56. Dart R.C. Tending the garden: a hunch about medical mythology. Ann Emerg Med 27 (1996) 362-363